Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-06-24, Stock:ABBV, The news for the past five days is as follows:
2020-06-17: NEWS1: AbbVie Declares Quarterly Dividend.NEWS2: Endometriosis: an invisible disease affecting half a million Canadians.NEWS3: U.K. trial sparks interest in dexamethasone’s potential as a treatment for severely ill COVID-19 patients.
2020-06-18: NEWS1: Buy These 4 Big Drugmakers to Keep Coronavirus Woes at Bay.NEWS2: RINVOQ™ (upadacitinib) Monotherapy Shows Improvement in Skin Clearance and Itch in First Phase 3 Study for Atopic Dermatitis.NEWS3: Alpine Immune Sciences and AbbVie Announce Option and License Agreement for the Development and Commercialization of ALPN-101.
2020-06-19: NEWS1: A Yes Vote for AMD Stock.NEWS2: Top Analyst Reports for AbbVie, Oracle & GlaxoSmithKline.NEWS3: AbbVie Stock Has More Upside, Analyst Says.NEWS4: The Zacks Analyst Blog Highlights: Eli Lilly & Company, AstraZeneca, AbbVie and Bristol-Myers Squibb.NEWS5: Is AbbVie (ABBV) Stock Undervalued Right Now?.NEWS6: Alpine Skyrockets on License Deal With AbbVie for ALPN-101.NEWS7: The Daily Biotech Pulse: Tiziana Snags A Patent Win, Decision Day For Nabriva And Evoke, IPOs.NEWS8: Pharma Stock Roundup: FDA Approvals to MRK, LLY, NVS and GSK's Drugs.
2020-06-22: NEWS1: The Zacks Analyst Blog Highlights: AbbVie, Oracle, GlaxoSmithKline, Kroger and Southern.NEWS2: Has AbbVie (ABBV) Outpaced Other Medical Stocks This Year?.NEWS3: The Extreme Risks of Trading Your Own Retirement Assets - June 22, 2020.NEWS4: FDA Accepts Supplemental Biologics License Application (sBLA) for BOTOX® (onabotulinumtoxinA) for the Treatment of Pediatric Patients with Neurogenic Detrusor Overactivity.
2020-06-23: NEWS1: Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?.NEWS2: AbbVie's (ABBV) sBLA for Botox Gets Acceptance From FDA.NEWS3: IMBRUVICA® (ibrutinib) Seeks to Expand U.S. Label with Long-Term Data in Waldenström's Macroglobulinemia (WM).

Answer: Decrease